GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, GPER1, HMGCR, HSD17B2, IGF1R, INSR, MMP2, MMP3, MMP9, POLB, PPARA, PTAFR, SRC, TEK, TYR |
11.5153 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.5153 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, HMGCR, HSPA1A, PIM1, PPARA, PTAFR, TBXAS1, TYR, XDH |
11.047 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, POLB, PPARA, PTAFR, SMAD3, SRC, TEK, TYR |
10.9976 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.7902 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP3, MMP9, POLB, PPARA, PTAFR, SMAD3, SRC, TEK, TYR |
10.0806 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.37284 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, BCL2, CDC25B, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIM1, PTAFR, SMAD3, SRC, TEK, XDH |
9.30932 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPER1, GPR35, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
9.25902 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPER1, GPR35, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
9.24054 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP3, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTAFR, PTPN1, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
9.23312 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, IGF1R, INSR, MMP2, PPARA, PTAFR, SMAD3, SRC, TEK |
9.04931 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, FABP3, FABP4, FUT7, HMGCR, HSD17B2, MET, PPARA, TBXAS1 |
9.02258 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, POLA1, POLB, PPARA, PTAFR, PTPN1, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
8.9221 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, INSR, PPARA, PTAFR, SRC, TEK |
8.52464 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FLT3, GPER1, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
8.36494 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CYP1B1, EGFR, F10, FLT3, GPER1, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, PTPN1, SRC, TEK, XDH |
8.29952 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, PTAFR, SRC, TYR |
7.93617 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPER1, GPR35, HCAR2, HMGCR, HSD17B2, HSPA1A, INSR, KDR, MET, POLA1, POLB, PPARA, PTAFR, SMAD3, SRC, TEK, XDH |
7.93617 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, GPER1, PTAFR, SRC, TEK, TYR |
7.91457 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP3, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
7.91457 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FLT3, GPER1, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP3, MMP9, PIM1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
7.77593 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
7.77593 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, POLB, PPARA, SMAD3, SRC, TEK, TYR |
7.65906 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, FABP4, FLT3, GPER1, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP2, MMP3, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
7.39427 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP3, MMP9, PTAFR, SMAD3, SRC |
7.33591 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
7.23784 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F10, FLT3, GPER1, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
7.2029 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, XDH |
7.17715 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP3, MMP9, SRC |
7.09141 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
7.00549 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK |
6.96674 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP3, MMP9, NUAK1, POLA1, POLB, PTAFR, PTPN1, SMAD3, SRC |
6.85285 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK |
6.78004 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GPER1, HMGCR, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
6.77217 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK |
6.73988 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, EGFR, ESRRB, FABP3, FLT3, GPER1, HMGCR, INSR, KDR, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
6.73988 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, EGFR, ESRRB, FABP3, FLT3, GPER1, HMGCR, INSR, KDR, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
6.73988 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GPER1, HMGCR, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
6.73206 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPER1, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
6.71181 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, XDH |
6.62147 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPER1, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
6.60964 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPER1, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP3, MMP9, PIM1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
6.52808 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, FABP4, GPER1, HMGCR, HSD17B2, IGF1R, INSR, MET, MMP1, MMP2, MMP3, MMP9, PIM1, PPARA, PTAFR, SMAD3, SRC, TEK, TYR |
6.48782 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK |
6.46977 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK |
6.40573 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, F10, FABP3, FABP4, FLT3, GPER1, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP3, MMP9, NUAK1, POLA1, POLB, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, TYR |
6.32446 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, GPER1, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK |
6.31135 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK |
6.30474 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, FABP3, FABP4, FUT7, HMGCR, MET, PPARA, TBXAS1 |
6.18731 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK |
6.18419 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, HMGCR, HSD17B2 |
6.17504 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK |
6.17408 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MMP2, PTAFR, SMAD3, SRC |
6.12273 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.0154 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK |
6.00691 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, GPER1, HMGCR, IGF1R, INSR, KDR, MMP2, MMP9, PIM1, PTAFR, TEK |
5.99735 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK |
5.95712 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
5.95693 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, F10, GPER1, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK |
5.94544 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, PTAFR, PTPN1, SRC, TEK, XDH |
5.88125 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, FABP4, FLT3, GPER1, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP2, MMP3, MMP9, NUAK1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
5.87019 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, AR, EGFR, FLT3, GPER1, HMGCR, INSR, KDR, PTPN1, SRC, TEK, XDH |
5.79096 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
5.74588 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, AR, DUSP3, EGFR, FLT3, GPER1, HMGCR, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
5.66317 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HMGCR, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TYR |
5.53752 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, PTAFR, PTPN1, SRC, TEK, XDH |
5.49572 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.48693 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, TBXAS1 |
5.46286 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, FLT3, GPER1, GPR35, INSR, MET, POLA1, POLB, SMAD3, SRC |
5.35967 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP4, FLT3, GPER1, HMGCR, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SRC, TEK, XDH |
5.32576 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PIM1, PPARA, SRC |
5.32576 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, EGFR, ESRRB, FLT3, GPER1, HMGCR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
5.32576 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, EGFR, HMGCR, HSPA1A, MMP2, POLB, PPARA, PTAFR, SMAD3, SRC, TEK, TYR |
5.24172 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD17B2, TBXAS1, TYR, XDH |
5.18818 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, SRC |
5.15422 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.13709 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.08568 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, INSR, PPARA, PTAFR, SRC |
5.05241 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, MMP9, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TYR |
5.0279 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, ESR1, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP3, MMP9, SMAD3, SRC, TEK |
5.01245 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
4.98968 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DUSP3, EGFR, ESR1, FABP4, GPER1, HMGCR, HSPA1A, IGF1R, MET, MMP2, MMP3, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.90265 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, EGFR, FLT3, GPER1, HMGCR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
4.89044 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPER1, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
4.87822 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, GPER1, HMGCR, HSPA1A, INSR, KDR, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
4.84381 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DUSP3, EGFR, GPER1, HMGCR, KDR, PTPN1, SRC, TEK |
4.81534 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, PTAFR, SRC |
4.81534 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, AR, BCL2, CYP19A1, DUSP3, EGFR, ESR1, ESR2, GPER1, HMGCR, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.80566 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP3, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTPN1, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
4.73426 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, F10, GPER1, INSR, MET, SRC, TEK, XDH |
4.73091 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, EGFR, ESR1, GPER1, IGF1R, INSR, MMP2, MMP3, MMP9, PTAFR, SRC |
4.66839 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, DUSP3, EGFR, FABP4, FLT3, GPER1, HMGCR, IGF1R, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
4.65912 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPER1, GPR35, HMGCR, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
4.64235 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, GPER1, HMGCR, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
4.64235 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, MET, PIM1, POLA1, SRC, TEK, TYR |
4.62554 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, EGFR, ESR1, FLT3, GPER1, HMGCR, HSPA1A, INSR, KDR, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
4.62554 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, EGFR, FLT3, GPER1, PTAFR, SRC |
4.62554 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP3, MMP9, SRC |
4.53494 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, BCL2, DUSP3, EGFR, ESR1, ESR2, GPER1, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
4.4745 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP3, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTAFR, PTPN1, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
4.46939 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, BCL2, DUSP3, EGFR, ESR1, ESR2, GPER1, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
4.46421 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.46421 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, INSR, PPARA, PTAFR, SRC |
4.45034 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, SRC |
4.44341 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
4.40371 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP3, MMP9, SRC |
4.31653 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
4.29441 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.28091 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
4.27305 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, DUSP3, EGFR, FABP4, FLT3, GPER1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
4.26838 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, GPER1, IGF1R, INSR, MMP2, MMP3, PPARA, PTAFR, SRC, TEK, TYR |
4.26456 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, EGFR, PPARA, SMAD3 |
4.24136 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, HMGCR, PTAFR, TYR |
4.19985 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTAFR |
4.19972 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, GPER1, HCAR2, HMGCR, HSD17B2 |
4.19972 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DUSP3, ESR1, GPER1, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
4.13084 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, GPER1, HMGCR, MMP2, MMP9, PTAFR |
4.10063 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, EGFR, FABP3, HMGCR, KDR, MMP3, POLB, PTAFR, SRC |
4.08595 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP3, MMP9, SRC |
4.03872 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, EGFR, ESRRB, GPER1, HCAR2, HMGCR, HSPA1A, KDR, MET, MMP9, PIM1, PTAFR, SMAD3, SRC, TEK |
4.02143 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP3, MMP9, SRC |
4.00547 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, BCL2, CDC25B, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
3.99321 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, GPER1, HMGCR, KDR, SRC, TEK |
3.96358 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, EGFR, GPER1, GPR35, HCAR2, HMGCR, HSPA1A, INSR, MMP9, PPARA, PTAFR, PTPN1, SMAD3, SRC |
3.96175 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
3.95878 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, GPER1, IGF1R, INSR, MMP2, PPARA, PTAFR, SRC, TEK, TYR |
3.94679 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
3.93697 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.92078 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, GPER1, HCAR2, HMGCR, PPARA, SRC, TEK |
3.86201 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
3.86085 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.83398 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, EGFR, ESR1, ESR2, FLT3, GPER1, HSPA1A, INSR, MET, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
3.82333 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.80295 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.78886 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, GPER1, HSPA1A, MMP2, MMP3, MMP9, NUAK1, POLA1, POLB, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK |
3.75264 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, POLB, PPARA, SMAD3, SRC, TEK |
3.73631 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, EGFR, ESR1, FLT3, GPER1, IGF1R, INSR, MMP2, PTAFR, SMAD3, SRC |
3.73241 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, EGFR, GPER1, HCAR2, HMGCR, KDR, SRC |
3.70729 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, MET, SRC, TEK |
3.67795 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, TBXAS1 |
3.67686 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.66615 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.66615 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, GPER1, PTAFR, SRC |
3.63327 |
[BP] GO:0003018 |
None
|
ADORA1, EGFR, GPER1, HMGCR, PTAFR, SRC, TEK |
3.63327 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, EGFR, FLT3, GPER1, HMGCR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
3.62504 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPER1, GPR35, INSR, MET, SMAD3 |
3.61769 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, MMP2, MMP9, PTAFR, SRC |
3.59973 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP3, MMP9, NUAK1, PIM1, POLB, PPARA, PTPN1, SMAD3, SRC, TEK, TYR, XDH |
3.5967 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.58945 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, SRC |
3.56796 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, GPR35, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP3, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
3.56796 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GPER1, GPR35, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PIM1, PTAFR, SMAD3, SRC, TEK, XDH |
3.53197 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP2, MMP3, MMP9, SRC, XDH |
3.52836 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, HMGCR, KDR, POLB, SRC |
3.52705 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, GPER1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
3.51269 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP3, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
3.50582 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, GPER1, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.46642 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
3.46254 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.43767 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, MMP3, SMAD3, XDH |
3.42215 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
3.4107 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP3, MMP9 |
3.37806 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR, HSPA1A |
3.32929 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, EGFR, GPER1, IGF1R, INSR, MMP2, MMP3, PTAFR, SRC |
3.314 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.30109 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, GPER1, PPARA, SMAD3, TEK |
3.30056 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, PTAFR, SRC |
3.29451 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.28285 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC |
3.26731 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK |
3.21665 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, PTAFR |
3.20934 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.20934 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.19659 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR, GPER1 |
3.19119 |
[BP] GO:0010675 |
None
|
ESRRB, GPER1, INSR, PPARA, PTAFR, SRC |
3.19119 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GPER1, IGF1R, INSR, PPARA, SRC, TEK |
3.18982 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.15703 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, GPER1, HSPA1A, MMP2, PPARA, PTPN1, SMAD3, SRC, TEK |
3.1563 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
AR, BCL2, DUSP3, EGFR, ESR1, ESR2, GPER1, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
3.1563 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK |
3.14199 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.14199 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR, HMGCR |
3.12739 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, SRC |
3.11598 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.10151 |
[BP] GO:0071383 |
None
|
AR, EGFR, FLT3, GPER1, SRC |
3.08003 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, ESR1, ESR2, GPER1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP3, MMP9, PTPN1, SMAD3, SRC, TEK |
3.06927 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, GPER1, INSR, SRC |
3.00378 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KDR, MMP3, PTAFR, SRC |
2.98797 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, BCL2, CA2, CYP19A1, DUSP3, ESR1, ESRRA, GPER1, HCAR2, HSPA1A, MMP2, PTAFR, PTPN1, SMAD3, SRC |
2.97878 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
2.97697 |
[BP] GO:0003013 |
None
|
ADORA1, EGFR, GPER1, HMGCR, PTAFR, SRC, TEK |
2.94771 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.94771 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, EGFR, GPER1, HCAR2, INSR, PTAFR, SMAD3, SRC |
2.92543 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, GPER1, KDR, SRC |
2.91043 |
[BP] GO:0043255 |
regulation of carbohydrate biosynthetic process
|
ESRRB, GPER1, INSR, PPARA, PTAFR |
2.9058 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, MET, MMP1, MMP3, SMAD3, SRC, TEK |
2.90236 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.90236 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, GPER1, PPARA, SMAD3, TEK |
2.87254 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC, TEK |
2.85101 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH |
2.83168 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, BCL2, CDC25B, EGFR, ESR1, FLT3, GPER1, HSPA1A, INSR, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
2.82216 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH |
2.82216 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, EGFR, GPER1, IGF1R, INSR, MMP2, PTAFR, SRC |
2.81979 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GPER1, GPR35, HCAR2, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP3, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTAFR, PTPN1, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
2.81161 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, TBXAS1, TYR |
2.80961 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.80625 |
[BP] GO:0042058 |
None
|
ADORA1, APP, EGFR, GPER1, MMP9 |
2.80508 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, GPER1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
2.80308 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GPER1, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP3, MMP9, PPARA, PTPN1, SMAD3, SRC, XDH |
2.79391 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.76591 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.76126 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ALOX15, ESR1, HSPA1A, MET, MMP1, MMP3, SRC |
2.72839 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
2.72677 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC, TEK |
2.71602 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AR, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, ESR1, INSR, MET, MMP2, POLB, SMAD3, SRC, TEK |
2.64737 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.64149 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTAFR, SRC |
2.63273 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTPN1, SRC |
2.61696 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PIM1, POLB, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK |
2.61261 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, MMP3, NUAK1, PTPN1, XDH |
2.60722 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.59612 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, GPER1, KDR, TEK |
2.5797 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK |
2.57416 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CYP19A1, HMGCR, PTAFR, TYR |
2.57058 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.55969 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, GPER1, HMGCR, KDR, MET, PPARA, SMAD3, TEK |
2.55937 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, BCL2, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3 |
2.5578 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP3, MMP9, NUAK1, PIM1, POLA1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
2.55747 |
[BP] GO:1901184 |
None
|
ADORA1, APP, EGFR, GPER1, MMP9 |
2.54799 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC |
2.5334 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.53008 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.51541 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.51541 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.51541 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.51541 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, POLB, TEK, TYR |
2.51527 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, GPER1, GPR35, SMAD3 |
2.51527 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CYP1B1, DUSP3, KDR, NUAK1, PPARA, PTAFR, SMAD3, SRC, TEK |
2.51527 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.50253 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.50253 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.50253 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, SMAD3, SRC, TEK |
2.48502 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC |
2.47847 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, GPER1, PPARA, SMAD3, TEK |
2.46962 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.45168 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GPER1, INSR, PPARA, PTAFR, SRC |
2.43043 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, TBXAS1, TYR |
2.43001 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.42769 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.42769 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.41744 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.401 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA3, PTAFR |
2.39386 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, EGFR, ESR1, FLT3, GPER1, PTAFR, SRC |
2.38081 |
[BP] GO:2000243 |
None
|
AR, INSR, PTAFR, SRC |
2.37379 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.36622 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, TBXAS1, TYR |
2.36564 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, BCL2, CYP1B1, FABP3, GPER1, HSPA1A, SMAD3, XDH |
2.35034 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.34907 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, ESRRB, GPER1, HMGCR, INSR, KDR, PIM1, SMAD3, SRC, TEK |
2.34724 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.30295 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ALOX15, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, POLA1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
2.29062 |
[BP] GO:0022612 |
gland morphogenesis
|
BCL2, EGFR, POLB |
2.28378 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.28378 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, KDR, SMAD3, SRC, TEK |
2.27365 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP3, MMP9, NUAK1, PIM1, POLB, PPARA, PTPN1, SMAD3, SRC, TEK |
2.24868 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.24836 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.24836 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.23644 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP3, MMP9, NUAK1, PIM1, POLA1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH |
2.23644 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, GPER1, HMGCR, PPARA, SMAD3, TEK |
2.2355 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, BCL2, CBR1, CDC25B, CYP1A1, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, HMGCR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
2.2257 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, POLB, PTPN1, SMAD3, SRC, TEK |
2.2237 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, BCL2, GPER1, HSPA1A, MMP9, PTPN1, SMAD3, SRC |
2.21217 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, GPER1, HCAR2, PTAFR, SRC |
2.20689 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, EGFR, ESR1, PPARA, SRC |
2.19531 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.19531 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.19531 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.19531 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.18137 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, INSR, KDR, MET, PPARA, PTAFR, SMAD3, SRC |
2.17268 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DUSP3, EGFR, GPER1, HSPA1A, INSR, PIM1, SMAD3, SRC |
2.17268 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, HSPA1A, PIM1 |
2.17268 |
[BP] GO:0097746 |
None
|
ADORA1, EGFR, GPER1, HMGCR, PTAFR |
2.17268 |
[BP] GO:0035296 |
None
|
ADORA1, EGFR, GPER1, HMGCR, PTAFR |
2.17268 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, GPER1 |
2.17268 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP2, MMP3, MMP9 |
2.17268 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.15844 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC |
2.15176 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, GPER1, KDR, TEK |
2.15176 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, INSR, KDR, MET, PPARA, PTAFR, SMAD3, SRC |
2.11819 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.11116 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.10776 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, GPER1, MMP9, SMAD3, SRC, XDH |
2.1033 |
[BP] GO:0032989 |
cellular component morphogenesis
|
APP, AR, AXL, BCL2, EGFR, MET, SRC, TEK |
2.09161 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.08749 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GPER1, IGF1R, INSR, SRC |
2.08646 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, GPER1 |
2.07481 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, GPER1 |
2.07481 |
[BP] GO:0050880 |
None
|
ADORA1, EGFR, GPER1, HMGCR, PTAFR |
2.06908 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, EGFR, ESR1, GPER1, GPR35, SMAD3 |
2.06092 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, HSPA1A, MMP9, PTPN1, SRC |
2.06092 |
[BP] GO:0035150 |
None
|
ADORA1, EGFR, GPER1, HMGCR, PTAFR |
2.05726 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, APP, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, PTPN1, SMAD3, SRC, TEK |
2.04583 |
[BP] GO:0036211 |
protein modification process
|
ALPL, APP, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, PTPN1, SMAD3, SRC, TEK |
2.04583 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, HSPA1A, MMP3, MMP9, NUAK1, POLA1, POLB, PTPN1, SRC |
2.04398 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, GPER1, IGF1R, INSR, KDR, MET, NUAK1, POLB, PTAFR, PTPN1, SRC, TEK |
2.04187 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA3, PTAFR |
2.03484 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.03458 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP2, MMP3, MMP9 |
2.02937 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.02937 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.02469 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP2, MMP3, MMP9 |
2.02333 |
[BP] GO:0040008 |
regulation of growth
|
APP, AR, BCL2, CSNK2A1, EGFR, ESR2, HSPA1A, INSR, PIM1, SMAD3 |
2.01937 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP2, MMP3, MMP9 |
2.01937 |
[BP] GO:2000241 |
regulation of reproductive process
|
AR, ESR1, INSR, PTAFR, SRC |
2.00119 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, F10, FLT3, GPER1, HMGCR, HSD17B2, PTPN1, TBXAS1 |
2.76126 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, EGFR, ESR1, F10, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTAFR, PTPN1, SMAD3, SRC, TEK |
2.34724 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.29382 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, AR, AURKB, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GPER1, HMGCR, HSD17B2, HSPA1A, INSR, KDR, MMP2, MMP9, PIM1, POLA1, PTAFR, PTPN1, SMAD3, SRC, TBXAS1, TYR, XDH |
2.07717 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, GPER1, HMGCR, HSD17B2, TBXAS1 |
2.03043 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GPER1, GPR35, HCAR2, HMGCR, HSD17B2, IGF1R, INSR, KDR, MET, MPEG1, PTAFR, PTPN1, SRC, TBXAS1, TEK, TYR |
2.00399 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP3, MMP9, PIM1, PPARA, PTPN1, SMAD3, TBXAS1, TYR, XDH |
19.825 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.997 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP3, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTAFR, PTPN1, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
12.3459 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
10.9485 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, F10, FLT3, FUT7, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP3, MMP9, NUAK1, PIM1, POLA1, POLB, PTPN1, SRC, TBXAS1, TEK, TYR, XDH |
10.9433 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.7902 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP3, MMP9, PPARA, PTPN1, SMAD3 |
8.8514 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP2, MMP3, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTPN1, SMAD3, TBXAS1, TYR, XDH |
8.2107 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP2, MMP3, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTPN1, SMAD3, TBXAS1, TYR, XDH |
7.91355 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, XDH |
7.8445 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.3242 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
7.2758 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.67682 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.62314 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.62147 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.62147 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD17B2, TBXAS1, TYR, XDH |
6.33862 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.1345 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, TYR |
6.1066 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.30002 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.21722 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC, TBXAS1 |
5.19805 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, GPER1, IGF1R, INSR, SHBG |
5.15228 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, SHBG |
5.12539 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC, TBXAS1 |
4.98968 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, PTAFR, TEK |
4.68255 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, TYR |
4.648 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, GPER1, PPARA, PTAFR, SHBG |
4.46825 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, POLA1, SRC, TBXAS1, XDH |
4.40834 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.11749 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.98709 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, PTAFR, TEK |
3.96175 |
[MF] GO:0019899 |
enzyme binding
|
APP, AR, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRB, HMGCR, HSPA1A, MET, POLA1, POLB, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK |
3.95702 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HMGCR, HSD17B2, XDH |
3.95626 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, PTAFR, SMAD3, TEK |
3.93743 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.92078 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK |
3.89032 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, PTAFR, TEK |
3.78886 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, HMGCR, MET, PPARA, PTPN1, SMAD3 |
3.49987 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC |
3.41684 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.34025 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, POLB, SRC, TEK |
3.30293 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.16901 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
3.1275 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.11746 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.90236 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.90236 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.81682 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.72677 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.401 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.24836 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.24836 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.24836 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, HMGCR, MET, PTPN1 |
2.24836 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD17B2 |
2.2355 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, EGFR, ESR1, ESR2, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, SMAD3, TYR, XDH |
2.20854 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA3, PTAFR |
2.15363 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AOX1, APP, AURKB, AXL, CSNK2A1, EGFR, F10, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTAFR, SRC, TEK, XDH |
2.1033 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, POLB, PPARA, PTPN1, SHBG, SMAD3, SRC, TBXAS1, TEK, XDH |
2.10258 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.09161 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.0751 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, PTPN1 |
2.03484 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.00119 |